Tom Strange
Private Equity Investor at iCON Infrastructure LLP
Profile
Tom is a Director and joined the team in 2023.
Tom has over 15 years of professional experience across a variety of clinical and operational roles.
Prior to joining iCON, Tom was Director of Corporate Strategy at MiroBio.
Tom has previously worked at McKinsey & Co and was an Associate Professor of Medicine at UCL.
Tom is primarily focused on overseeing investments across iCON’s funds.
Tom holds a Master’s degree in Bioscience Enterprise (Cambridge University), as well as a Medical Degree & Bachelor’s in Medical Science (Nottingham University).
He is also a Fellow of the Royal College of Radiologists and a Member of the Royal College of Surgeons of England.
Tom Strange active positions
Companies | Position | Start |
---|---|---|
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure LLP is a private equity firm founded in 2004 by Paul Malan. The firm is headquartered in London, United Kingdom with offices in Germany, Canada and the United States. | Private Equity Investor | 2023-05-31 |
Former positions of Tom Strange
Companies | Position | End |
---|---|---|
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Private Equity Investor | 2022-10-31 |
Training of Tom Strange
University of Cambridge | Graduate Degree |
The University of Nottingham | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
iCON Infrastructure LLP
iCON Infrastructure LLP Investment ManagersFinance iCON Infrastructure LLP is a private equity firm founded in 2004 by Paul Malan. The firm is headquartered in London, United Kingdom with offices in Germany, Canada and the United States. | Finance |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Tom Strange